Previous close | 0.6600 |
Open | 0.5400 |
Bid | 0.4000 |
Ask | 1.9400 |
Strike | 87.50 |
Expiry date | 2025-01-17 |
Day's range | 0.5400 - 0.5400 |
Contract range | N/A |
Volume | |
Open interest | 2.92k |
Although the revenue and EPS for Gilead (GILD) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
The biotech reported a loss for the quarter of $1.32 per share, better than the FactSet consensus estimate of a loss of $1.49 per share.
Comprehensive Analysis of Gilead's First Quarter Financial Performance